Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: Haolin Ni who wrote (124)	12/9/1998 8:48:00 PM
From: Mr Metals	Respond to of 1084

LOL.. MM

To: Haolin Ni who wrote (124)	12/9/1998 8:51:00 PM
From: h.l. meeks	Read Replies (1) \| Respond to of 1084

ASTM has half the float of GERN, and a fourth of that of ENMD.......if ASTM breaks the old highs in the morning the momentum players will force shorts into margin calls......I short sell regularly, but never a stock with a 5MM share float. Way too easy short squeeze. Lots of stock was already sold short this afternoon. Bet those guys aren't sleeping too well tonight.

To: Haolin Ni who wrote (124)	12/9/1998 8:52:00 PM
From: Bo Didley	Read Replies (2) \| Respond to of 1084

There is always some short who won't be sleeping tonight One of my friends shorted GERN at $10. He covered the next morning at $23. Sure way to lose money being short this stock. ASTM has a product that EVERY HOSPITAL in the WORLD wants: The AastromReplicell(TM) System is an automated clinical system designed to enable hospitals to produce patient-specific cells for use in the treatment of a broad range of diseases including cancer, infectious diseases, auto-immune diseases as well as cells used in the restoration of solid tissues. This is better than GERN. They have this product that will bring in huge revenues! bo